STAB
Royal Bank of Canada’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-217
| Closed | – | – | 7263 |
|
2022
Q4 | $0 | Buy |
217
+208
| +2,311% | – | ﹤0.01% | 7481 |
|
2022
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 7566 |
|
2022
Q1 | – | Sell |
-5,000
| Closed | -$12K | – | 7558 |
|
2021
Q4 | $12K | Buy |
+5,000
| New | +$12K | ﹤0.01% | 6481 |
|
2021
Q3 | – | Sell |
-3,620
| Closed | -$20K | – | 7392 |
|
2021
Q2 | $20K | Hold |
3,620
| – | – | ﹤0.01% | 6076 |
|
2021
Q1 | $19K | Hold |
3,620
| – | – | ﹤0.01% | 5965 |
|
2020
Q4 | $12K | Hold |
3,620
| – | – | ﹤0.01% | 5758 |
|
2020
Q3 | $7K | Sell |
3,620
-5,000
| -58% | -$9.67K | ﹤0.01% | 5569 |
|
2020
Q2 | $22K | Buy |
8,620
+5,000
| +138% | +$12.8K | ﹤0.01% | 5086 |
|
2020
Q1 | $6K | Sell |
3,620
-5
| -0.1% | -$8 | ﹤0.01% | 5503 |
|
2019
Q4 | $2K | Buy |
3,625
+1
| +0% | +$1 | ﹤0.01% | 5985 |
|
2019
Q3 | $4K | Sell |
3,624
-3
| -0.1% | -$3 | ﹤0.01% | 5488 |
|
2019
Q2 | $5K | Sell |
3,627
-4
| -0.1% | -$6 | ﹤0.01% | 5429 |
|
2019
Q1 | $6K | Hold |
3,631
| – | – | ﹤0.01% | 5285 |
|
2018
Q4 | $4K | Buy |
3,631
+3,620
| +32,909% | +$3.99K | ﹤0.01% | 5398 |
|
2018
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 6353 |
|
2018
Q1 | – | Sell |
-1
| Closed | – | – | 6105 |
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6154 |
|
2017
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6205 |
|
2016
Q1 | – | Sell |
-2,620
| Closed | -$9K | – | 5846 |
|
2015
Q4 | $9K | Buy |
+2,620
| New | +$9K | ﹤0.01% | 5241 |
|
2014
Q2 | – | Sell |
-35,000
| Closed | -$24K | – | 5556 |
|
2014
Q1 | $24K | Hold |
35,000
| – | – | ﹤0.01% | 4602 |
|
2013
Q4 | $41K | Hold |
35,000
| – | – | ﹤0.01% | 4360 |
|
2013
Q3 | $55K | Hold |
35,000
| – | – | ﹤0.01% | 4214 |
|
2013
Q2 | $55K | Buy |
+35,000
| New | +$55K | ﹤0.01% | 4033 |
|